Abstract

BackgroundOnchocerciasis control for years has been based on mass drug administration (MDA) with ivermectin (IVM). Adherence to IVM repeated treatment has recently been shown to be a confounding factor for onchocerciasis elimination precisely in rain forest areas where transmission continues and Loa loa co-exists with Onchocerca volvulus. In this study, participants’ oral declarations were used as proxy to determine the relationship between adherence to IVM treatment and parasitological indicators of onchocerciasis in the rain forest area of Cameroon with more than a decade of MDA.MethodsParticipants were recruited based on their IVM intake profile with the aid of a semi-structured questionnaire. Parasitological examinations (skin sniping and nodule palpation) were done on eligible candidates. Parasitological indicators were calculated and correlated to IVM intake profile.ResultsOf 2,364 people examined, 15.5 % had never taken IVM. The majority (40.4 %) had taken the drug 1–3 times while only 18 % had taken ≥ 7 times. Mf and nodule prevalence rates were still high at 47 %, 95 % CI [44.9–49.0 %] and 36.4 %, 95 % CI [34.4–38.3 %] respectively. There was a treatment-dependent reduction in microfilaria prevalence (rs =−0.986, P = 0.01) and intensity (rs =−0.96, P = 0.01). The highest mf prevalence (59.7 %) was found in the zero treatment group and the lowest (33.9 %) in the ≥ 7 times treatment group (OR = 2.8; 95 % CI [2.09–3.74]; P < 0.001). Adults with ≥ 7 times IVM intake were 2.99 times more likely to have individuals with no microfilaria compared to the zero treatment group (OR = 2.99; 95 % CI [2.19–4.08], P < 0.0001). There was no clear correlation between treatment and nodule prevalence and intensity.ConclusionAdherence to ivermectin treatment is not adequate in this rain forest area where L. loa co-exists with O. volvulus. The prevalence and intensity of onchocerciasis remained high in individuals with zero IVM intake after more than a decade of MDA. Our findings show that using parasitological indicators, reduction in prevalence is IVM intake-dependent and that participants’ oral declaration of treatment adherence could be relied upon for impact studies. The findings are discussed in the context of challenges for the elimination of onchocerciasis in this rain forest area.

Highlights

  • Onchocerciasis control for years has been based on mass drug administration (MDA) with ivermectin (IVM)

  • The prevalence and intensity of onchocerciasis remained high in individuals with zero IVM intake after more than a decade of MDA

  • Our findings show that using parasitological indicators, reduction in prevalence is IVM intakedependent and that participants’ oral declaration of treatment adherence could be relied upon for impact studies

Read more

Summary

Introduction

Onchocerciasis control for years has been based on mass drug administration (MDA) with ivermectin (IVM). Since the creation of APOC in 1995, the control of onchocerciasis has been based on annual mass drug distribution (MDA) in most endemic countries [12]. This was done by establishing the Community-Directed Treatment with ivermectin (CDTI). The main objective of APOC was to reduce the prevalence and transmission of onchocerciasis to a point where the disease will no longer be a public health problem in countries not previously covered by the Onchocerciasis Control Programme (OCP). Since with CDTI, participants are not forced to take the drug but instead are sensitised and educated on its benefits, the term adherence seems more relevant

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call